Abstract
ObjectiveIntrahepatic cholangiocarcinoma (ICC) exhibits very low response rate to immune checkpoint inhibitors (ICIs) and the underlying mechanism is largely unknown. We investigate the tumour immune microenvironment (TIME) of ICCs and...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have